Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing

    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 116
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.04-054 - Mitochondrial Status in Peripheral Blood Mononuclear Cells in Relation to Cognitive Impairment in Lung Cancer Patients

      09:30 - 09:30  |  Author(s): R. Ramlau

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P1.04-075 - Kynurenine Pathway Activity in Peripheral Blood Mononuclear Cells and Cognitive Functions in Lung Cancer Patients

      09:30 - 09:30  |  Author(s): R. Ramlau

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 01 - Chemotherapy Developments for Lung Cancer

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 7
    • Moderators:G. Blumenschein
    • Coordinates: 9/07/2015, 10:45 - 12:15, 401-404
    • +

      ORAL01.03 - A Randomized Phase 2 Trial of Vintafolide and Docetaxel in Folate-Receptor Positive (FR+) Advanced NSCLC Patients: Final Efficacy Results

      11:07 - 11:18  |  Author(s): N. Hanna

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      ORAL01.05 - Phase I/II Dose Escalation Study of Immunoconjugate L-DOS47 as a Monotherapy in Non-Squamous Non-Small Cell Lung Cancer Patients

      11:28 - 11:39  |  Author(s): D. Kowalski

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ORAL 32 - EGFR WT and MT Targeting

    • Type: Oral Session
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 8
    • Moderators:K.J. O'Byrne
    • Coordinates: 9/09/2015, 16:45 - 18:15, Four Seasons Ballroom F3+F4
  • +

    ORAL 34 - Quality/Survival/Prognosis in Localized Lung Cancer

    • Type: Oral Session
    • Track: Treatment of Localized Disease - NSCLC
    • Presentations: 8
    • Moderators:B.C. Cho
    • Coordinates: 9/09/2015, 16:45 - 18:15, 201+203
    • +

      ORAL34.03 - Prognostic Factors in Early Stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study

      17:07 - 17:18  |  Author(s): B.C. Cho

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.